Epigenomics-Guided Multi-Omics Integration Uncovers a Lipid-Metabolic Signature with Translational Utility in Bladder Cancer
Background: Bladder cancer (BLCA) exhibits marked heterogeneity, and current classifiers provide limited guidance for prognosis or treatment. Because epigenetic reprogramming and metabolic rewiring jointly shape BLCA biology, we sought to identify epigenomically informed biomarkers with functional relevance. Methods: Epigenome (genome-wide promoter DNA methylation) and matched transcriptome (RNA sequencing) profiles from tumor and adjacent normal samples were integrated to identify genes with concordant differen…
Computational and Structural Biotechnology Journal
ace







